Trident Pharmaceuticals Inc.
Trident Pharmaceuticals Inc. is a joint venture with Hunter-Fleming, set up to fast track the development of HF1020, a compound that embraces a novel concept for treating asthma and allergic conditions. The company came from an extensive research programme at Bristol University's Medical School.
Contact: Dr Jim Murray
Email: jrmludwell@aol.com